Valeant Pharmaceuticals

Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln

Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln

NASDAQ

On verge of $13B merger, Valeant and Actavis stop talking

On verge of $13B merger, Valeant and Actavis stop talking

Fierce Pharma

Valeant Pharmaceuticals in Talks to Buy Actavis

Valeant Pharmaceuticals in Talks to Buy Actavis

Wall Street Journal

Valeant completes tender offer for Obagi Medical

Valeant completes tender offer for Obagi Medical

Yahoo/Fly on the Wall

4 Stocks Pushing The Drugs Industry Downward

4 Stocks Pushing The Drugs Industry Downward

TheStreet.com

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

Pharmabiz

Valeant, Actavis team up on two more authorized generics

Valeant, Actavis team up on two more authorized generics

Fierce Pharma

Mylan rains on Valeant parade with Zovirax generic

Mylan rains on Valeant parade with Zovirax generic

Fierce Pharma

Merz Pharma drops out of race for Obagi Medical

Merz Pharma drops out of race for Obagi Medical

Reuters